compounded semaglutide salt States cracking down on compounding pharmacies selling knockoff weight-loss drugs Semaglutide | C187H291N45O59 | CID

In the SUSTAIN-6 trial, injectable semaglutide demonstrated a notable effect in reducing the incidence of nonfatal stroke (hazard ratio [HR] 0.61

Injectable formulations are administered via subcutaneous injection, which is the same delivery method used by FDA-approved brand-name GLP-1 medications

GLP-1 Semglutide can be paired with other weight loss treatments like laser lipo and body contouring for enhanced results

Requires frequent injections (weekly or biweekly)

It is important to note that whilst these findings are promising, there is no official consensus on GLP-1 receptor agonists being prescribed specifically as anti-inflammatory agents